- cafead   Nov 29, 2023 at 12:13: PM
via On a roll with Vyvgart—which is on its way to blockbuster sales in just its second year on the market for generalized myasthenia gravis (gMG)—argenx’s heat check in another indication has missed badly.
article source
article source